In this system, administration of IPF MPCs to immunocompromised NOD/SCID/IL2rγ/B2M (NSG) mice pretreated with intratracheal bleomycin results in nonresolving interstitial lung fibrosis (9). Here, IL2RG is linked to idiopathic pulmonary fibrosis.